HU9302820D0 - Process for separation of biomolecules with application of linear polymers - Google Patents

Process for separation of biomolecules with application of linear polymers

Info

Publication number
HU9302820D0
HU9302820D0 HU9302820A HU9302820A HU9302820D0 HU 9302820 D0 HU9302820 D0 HU 9302820D0 HU 9302820 A HU9302820 A HU 9302820A HU 9302820 A HU9302820 A HU 9302820A HU 9302820 D0 HU9302820 D0 HU 9302820D0
Authority
HU
Hungary
Prior art keywords
biomolecules
separation
application
linear polymers
polymers
Prior art date
Application number
HU9302820A
Other languages
English (en)
Other versions
HUT65139A (en
Inventor
James E Woiszwillo
Original Assignee
Middlesex Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Middlesex Sciences Inc filed Critical Middlesex Sciences Inc
Publication of HU9302820D0 publication Critical patent/HU9302820D0/hu
Publication of HUT65139A publication Critical patent/HUT65139A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
HU9302820A 1992-01-07 1993-01-07 Process for separating biomolecules by using linear polymers HUT65139A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/817,610 US5525519A (en) 1992-01-07 1992-01-07 Method for isolating biomolecules from a biological sample with linear polymers

Publications (2)

Publication Number Publication Date
HU9302820D0 true HU9302820D0 (en) 1993-12-28
HUT65139A HUT65139A (en) 1994-04-28

Family

ID=25223460

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9302820A HUT65139A (en) 1992-01-07 1993-01-07 Process for separating biomolecules by using linear polymers

Country Status (7)

Country Link
US (2) US5525519A (hu)
EP (1) EP0574575A1 (hu)
JP (2) JPH06503366A (hu)
AU (1) AU667508B2 (hu)
CA (1) CA2104772A1 (hu)
HU (1) HUT65139A (hu)
WO (1) WO1993014110A1 (hu)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
US5554730A (en) * 1993-03-09 1996-09-10 Middlesex Sciences, Inc. Method and kit for making a polysaccharide-protein conjugate
DE69408527T2 (de) * 1993-03-09 1998-06-04 Epic Therapeutics Inc Makromolekulare mikropartikel und verfahren zu ihrer herstellung
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
WO1996020012A2 (en) * 1994-12-23 1996-07-04 Middlesex Sciences, Inc. Methods for preparing and purifying macromolecular conjugates
GB9810799D0 (en) * 1998-05-21 1998-07-15 Boots Co Plc Antimicrobial agent
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
EP2280004B1 (en) 1999-06-29 2016-04-20 MannKind Corporation Pharmaceutical formulations comprising insulin complexed with a diketopiperazine
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US7374782B2 (en) 2000-10-27 2008-05-20 Baxter International Inc. Production of microspheres
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
US20030064033A1 (en) * 2001-08-16 2003-04-03 Brown Larry R. Propellant-based microparticle formulations
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
US7459154B2 (en) * 2002-12-26 2008-12-02 Cell Genesys, Inc. Methods and reagents for the enhancement of virus transduction in the bladder epithelium
WO2005035088A2 (en) * 2003-07-18 2005-04-21 Baxter International, Inc. Method for preparing small spherical by controlled phase separation
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
CA2532874A1 (en) * 2003-07-22 2005-02-03 Baxter International Inc. Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
ES2442115T3 (es) * 2004-05-12 2014-02-10 Baxter International Inc. Microesferas que contienen oligonucleótidos, su utilización para la preparación de un medicamento para el tratamiento de la diabetes tipo 1
WO2005112893A1 (en) 2004-05-12 2005-12-01 Baxter International Inc. Microspheres comprising protein and showing injectability at high concentrations of said agent
EP2072040B1 (en) 2004-05-12 2013-05-01 Baxter International Inc. Therapeutic use of nucleic acid micropheres
US8410246B2 (en) 2004-06-17 2013-04-02 Thrasos, Inc. TDF-related compounds and analogs thereof
JP5078014B2 (ja) 2004-08-20 2012-11-21 マンカインド コーポレイション ジケトピペラジン合成の触媒反応
MX2007002189A (es) 2004-08-23 2008-01-11 Mannkind Corp Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
CA2604225A1 (en) * 2005-04-27 2006-11-02 Baxter International Inc. Surface-modified microparticles and methods of forming and using the same
US7803404B2 (en) 2005-09-14 2010-09-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
SI2497780T1 (sl) 2005-09-20 2015-08-31 Thrasos Innovation, Inc. Spojine, povezane s TDF, in njihovi analogi
IN2015DN00888A (hu) 2006-02-22 2015-07-10 Mannkind Corp
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
US7964574B2 (en) * 2006-08-04 2011-06-21 Baxter International Inc. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
MX2009003661A (es) * 2006-10-06 2009-04-22 Baxter Int Microcapsulas que contienen microparticulas modificadas en la superficie y metodos para formar y utilizar las mismas.
US8569464B2 (en) * 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
US8163886B2 (en) * 2006-12-21 2012-04-24 Emd Millipore Corporation Purification of proteins
AU2008209404B2 (en) * 2007-01-22 2012-08-16 Genentech, Inc. Polyelectrolyte precipitation and purification of antibodies
US8086409B2 (en) * 2007-01-30 2011-12-27 The Trustees Of Columbia University In The City Of New York Method of selecting genes from continuous gene expression data based on synergistic interactions among genes
AU2008214319A1 (en) * 2007-02-06 2008-08-14 Incept, Llc Polymerization with precipitation of proteins for elution in physiological solution
US8808747B2 (en) * 2007-04-17 2014-08-19 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
CA2720048A1 (en) * 2008-04-16 2009-10-22 Biogen Idec Ma Inc. Method of isolating biomacromolecules using polyalkylene glycol and transition metals
ES2554168T3 (es) 2008-04-18 2015-12-16 Baxter International Inc. Composición basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nueva aparición
WO2009151514A1 (en) * 2008-06-11 2009-12-17 Millipore Corporation Stirred tank bioreactor
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
KR101933816B1 (ko) 2008-06-13 2019-03-29 맨카인드 코포레이션 건조 분말 흡입기 및 약물 투여 시스템
WO2009155581A1 (en) 2008-06-20 2009-12-23 Mannkind Corporation An interactive apparatus and method for real-time profiling of inhalation efforts
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
WO2010074953A1 (en) 2008-12-16 2010-07-01 Millipore Corporation Stirred tank reactor and method
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
PL2405963T3 (pl) 2009-03-11 2014-04-30 Mannkind Corp Urządzenie, układ i sposób pomiaru oporu inhalatora
BRPI1013154B1 (pt) 2009-06-12 2020-04-07 Mannkind Corp Micropartículas de dicetopiperazina com áreas de superfície específicas definidas, pó seco compreendendo as referidas micropartículas, método para formação das referidasmicropartículas e formação de micropartículas de fumaril diacetopiperazina, uso das referidas micropartículas e sistema de inalação
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
US8691918B2 (en) 2010-05-17 2014-04-08 Emd Millipore Corporation Stimulus responsive polymers for the purification of biomolecules
MX359281B (es) 2010-06-21 2018-09-21 Mannkind Corp Sistema y metodos para suministrar un farmaco en polvo seco.
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
IN2014DN03093A (hu) 2011-10-24 2015-05-15 Mannkind Corp
WO2013114373A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Inhalable liquid formulations of dnase i
SG10201605800UA (en) 2012-07-12 2016-09-29 Mannkind Corp Dry powder drug delivery system and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
WO2014097289A1 (en) * 2012-12-20 2014-06-26 Omrix Biopharmaceuticals Ltd. Viral inactivated biological mixture
KR102499439B1 (ko) 2013-03-15 2023-02-13 맨카인드 코포레이션 미세결정성 디케토피페라진 조성물 및 방법
CA2918369C (en) 2013-07-18 2021-06-29 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
WO2015021064A1 (en) 2013-08-05 2015-02-12 Mannkind Corporation Insufflation apparatus and methods
KR102356757B1 (ko) * 2013-10-18 2022-02-03 노바셉 이큅먼트 솔루션즈 단백질 정제
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide
JP6583766B2 (ja) * 2015-02-02 2019-10-02 学校法人北里研究所 タンパク質分離方法、タンパク質分析方法、及びタンパク質分離キット
US10426796B2 (en) 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
EP4138884A1 (en) 2020-04-20 2023-03-01 Sorrento Therapeutics, Inc. Pulmonary administration of ace2 polypeptides
CN115521895B (zh) * 2021-06-24 2024-04-05 上海思路迪生物医学科技有限公司 水溶性蛋白作为外泌体提取增强剂的应用及外泌体提取试剂
EP4163369A1 (en) 2021-10-08 2023-04-12 AXAGARIUS GmbH & Co. KG Use of mixtures of polyvinylpyrrolidone and ammonium sulfate in the isolation of nucleic acids

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3897414A (en) * 1969-09-12 1975-07-29 Pharmacia Fine Chemicals Ab Method of fractionating a mixture of high molecular substances of different physical characteristics
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
US3790552A (en) * 1972-03-16 1974-02-05 Us Health Method of removing hepatitis-associated antigen from a protein fraction using polyethylene glycol
CA1064396A (en) * 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
DE2512735A1 (de) * 1975-03-22 1976-09-30 Henkel & Cie Gmbh Verfahren zur gewinnung von proteinen aus waessrigen protein- loesungen
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
DK139056B (da) * 1976-04-06 1978-12-11 Nordisk Insulinlab Fremgangsmåde til udvinding af immunoglobulin, der er egnet til intravenøs indgivelse.
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
DK144731C (da) * 1976-07-30 1982-10-18 Nordisk Insulinlab Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
DK25877A (da) * 1977-01-21 1978-08-15 Nordisk Insulinlab Fremgangsmaade til udvinding af renset albumin fra blodplasma
JPS53127808A (en) * 1977-04-12 1978-11-08 Green Cross Corp:The Preparation of human albumin
JPS5843369B2 (ja) * 1977-09-10 1983-09-27 森六株式会社 血清蛋白質の分画方法
SU1109170A1 (ru) * 1982-03-30 1984-08-23 Московский научно-исследовательский институт вакцин и сывороток им.И.И.Мечникова Способ получени иммуноглобулина
JPS59157017A (ja) * 1983-02-25 1984-09-06 Green Cross Corp:The 静脈投与用γ−グロブリン製剤
JPS6042336A (ja) * 1983-08-18 1985-03-06 Nippon Seiyaku Kk 免疫グロブリンの製造方法
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DE3509892C2 (de) * 1985-03-19 1994-04-21 Westfalia Separator Ag Verfahren zum Nachklären und Stabilisieren von Polyphenole und/oder Eiweißstoffe enthaltenden Flüssigkeiten und Getränken, insbesondere von Bier
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
FR2582515B1 (fr) * 1985-05-30 1988-11-04 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
SE459005B (sv) * 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
SE462100B (sv) * 1985-08-08 1990-05-07 Perstorp Ab Komposition och dess anvaendning i ett tvaa- eller flerfassystem
AU591964B2 (en) * 1986-01-06 1989-12-21 University Of Melbourne, The Collagen products
DE3606382A1 (de) * 1986-02-27 1987-09-03 Henkel Kgaa Verbesserter klebestift
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
US5135875A (en) * 1990-08-15 1992-08-04 Abbott Laboratories Protein precipitation reagent
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
US5288853A (en) * 1992-04-30 1994-02-22 Alpha Therapeutic Corporation Factor viii purification process

Also Published As

Publication number Publication date
JPH06503366A (ja) 1994-04-14
EP0574575A1 (en) 1993-12-22
US5599719A (en) 1997-02-04
JPH09157288A (ja) 1997-06-17
US5525519A (en) 1996-06-11
HUT65139A (en) 1994-04-28
AU3434493A (en) 1993-08-03
CA2104772A1 (en) 1993-07-08
WO1993014110A1 (en) 1993-07-22
AU667508B2 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
HU9302820D0 (en) Process for separation of biomolecules with application of linear polymers
ZA905308B (en) Process for the preparation of cycloolefin polymers
AP9300537A0 (en) Novel process
GB9204064D0 (en) Method of identifying polymer materials
GB9209687D0 (en) Novel process
ZA933521B (en) Process for the separation of cobalt
HUT64763A (en) Process for the production of cyclobutane-purines
GB9221527D0 (en) Moulding process
IL108015A0 (en) Process for the production of polypeptides
EP0405467A3 (en) A process for the determination of interleukins
EP0435042A3 (en) Method for thermoplastics postforming
LTIP217A (en) Process for the polymerisation of epoxycompounds
ZA9410171B (en) Process for the preparation of polyolefins
GB9214116D0 (en) Separation process
GB9211730D0 (en) Separation process
GB9210709D0 (en) Separation process
GB9208793D0 (en) Separation process
GB9203710D0 (en) Separation process
GB8907642D0 (en) Process for purification of biomolecules
GB9215494D0 (en) Process for the conversion of polymers
GB9213772D0 (en) Process for the conversion of polymers
GB9201855D0 (en) Enhanced separation process
IL92698A0 (en) Process for the separation of gases
PL282161A1 (en) Method of stabilizing the polyethylene thermooxidizing process
IL96857A0 (en) Process for the separation of gases

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee